BACKGROUND: An alginate-based matrix supports the three-dimensional (3D) architecture of non-human primate follicles and, in the presence of FSH, permits the in vitro development of pre-antral follicles to the small antral stage, including the production of ovarian steroids and paracrine factors. The current study investigated the ability of gonadotrophins, fetuin and oxygen (O₂) to improve primate follicle growth and oocyte maturation in vitro. METHODS: Macaque secondary follicles were isolated from the early follicular phase ovaries, encapsulated in a sodium alginate matrix and cultured individually for 40 days in supplemented medium. The effects of recombinant human (rh) FSH (15, 3 and 0.3 ng/ml for high, medium and low FSH, respectively), bovine fetuin (1 or 0 mg/ml) and O₂ (5 or 20% v/v) were examined. Half of the follicles in each culture condition received rhLH on Day 30-40. Follicles that reached antral stage were treated with rh chorionic gonadotrophin for 34 h to initiate oocyte meiotic maturation. Media were analyzed for ovarian steroids and anti-müllerian hormone (AMH). RESULTS: Improved culture conditions supported non-human primate, secondary follicle growth to the antral stage and, for the first time, promoted oocyte maturation to the MII stage. In the presence of fetuin at 5% O₂, follicles had the highest survival rate if cultured with high or medium FSH, whereas follicles grew to larger diameters at Week 5 in low FSH. Oocyte health and maturation were promoted under 5% O₂. High FSH stimulated steroid production by growing follicles, and steroidogenesis by follicles cultured with low FSH was promoted by LH. AMH biosynthesis was elevated with high compared with low FSH and for longer under 5% O₂ than under 20% O₂. CONCLUSIONS: This encapsulated 3D culture model permits further studies on the endocrine and local factors that influence primate follicle growth and oocyte maturation, with relevance to enhancing fertility preservation options in women.
BACKGROUND: An alginate-based matrix supports the three-dimensional (3D) architecture of non-human primate follicles and, in the presence of FSH, permits the in vitro development of pre-antral follicles to the small antral stage, including the production of ovarian steroids and paracrine factors. The current study investigated the ability of gonadotrophins, fetuin and oxygen (O₂) to improve primate follicle growth and oocyte maturation in vitro. METHODS: Macaque secondary follicles were isolated from the early follicular phase ovaries, encapsulated in a sodium alginate matrix and cultured individually for 40 days in supplemented medium. The effects of recombinant human (rh) FSH (15, 3 and 0.3 ng/ml for high, medium and low FSH, respectively), bovine fetuin (1 or 0 mg/ml) and O₂ (5 or 20% v/v) were examined. Half of the follicles in each culture condition received rhLH on Day 30-40. Follicles that reached antral stage were treated with rh chorionic gonadotrophin for 34 h to initiate oocyte meiotic maturation. Media were analyzed for ovarian steroids and anti-müllerian hormone (AMH). RESULTS: Improved culture conditions supported non-human primate, secondary follicle growth to the antral stage and, for the first time, promoted oocyte maturation to the MII stage. In the presence of fetuin at 5% O₂, follicles had the highest survival rate if cultured with high or medium FSH, whereas follicles grew to larger diameters at Week 5 in low FSH. Oocyte health and maturation were promoted under 5% O₂. High FSH stimulated steroid production by growing follicles, and steroidogenesis by follicles cultured with low FSH was promoted by LH. AMH biosynthesis was elevated with high compared with low FSH and for longer under 5% O₂ than under 20% O₂. CONCLUSIONS: This encapsulated 3D culture model permits further studies on the endocrine and local factors that influence primate follicle growth and oocyte maturation, with relevance to enhancing fertility preservation options in women.
Authors: Min Xu; Susan L Barrett; Erin West-Farrell; Laxmi A Kondapalli; Sarah E Kiesewetter; Lonnie D Shea; Teresa K Woodruff Journal: Hum Reprod Date: 2009-07-13 Impact factor: 6.918
Authors: J Donnez; M M Dolmans; D Demylle; P Jadoul; C Pirard; J Squifflet; B Martinez-Madrid; A van Langendonckt Journal: Lancet Date: 2004 Oct 16-22 Impact factor: 79.321
Authors: Rebecca S Brogan; Scott Mix; Muraly Puttabyatappa; Catherine A VandeVoort; Charles L Chaffin Journal: Fertil Steril Date: 2009-02-24 Impact factor: 7.329
Authors: David Tagler; Tao Tu; Rachel M Smith; Nicholas R Anderson; Candace M Tingen; Teresa K Woodruff; Lonnie D Shea Journal: Tissue Eng Part A Date: 2012-03-02 Impact factor: 3.845
Authors: Marina C Peluffo; Alison Y Ting; Alberuni M Zamah; Marco Conti; Richard L Stouffer; Mary B Zelinski; Jon D Hennebold Journal: Hum Reprod Date: 2012-05-16 Impact factor: 6.918
Authors: Jing Xu; Fuhua Xu; John H Letaw; Byung S Park; Robert P Searles; Betsy M Ferguson Journal: J Assist Reprod Genet Date: 2016-09-15 Impact factor: 3.412
Authors: Jing Xu; Min Xu; Marcelo P Bernuci; Thomas E Fisher; Lonnie D Shea; Teresa K Woodruff; Mary B Zelinski; Richard L Stouffer Journal: Adv Exp Med Biol Date: 2013 Impact factor: 2.622
Authors: Robin M Skory; Beatriz Peñalver Bernabé; Eugene Galdones; Linda J Broadbelt; Lonnie D Shea; Teresa K Woodruff Journal: Mol Reprod Dev Date: 2013-01-30 Impact factor: 2.609